Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
211. lappuse
... grams . ( 2 ) Pharmaceutical preparations con- taining not more than 16.2 milligrams ( 1⁄4 grain ) morphine , or any of its salts , per 29.5729 cubic centimeters ( 1 fluid ounce ) or per 28.3 grams ( 1 avoirdupois ounce ) ; ( 3 ) ...
... grams . ( 2 ) Pharmaceutical preparations con- taining not more than 16.2 milligrams ( 1⁄4 grain ) morphine , or any of its salts , per 29.5729 cubic centimeters ( 1 fluid ounce ) or per 28.3 grams ( 1 avoirdupois ounce ) ; ( 3 ) ...
224. lappuse
... grams calcium carbonate ) . ( e ) Citrate - containing active ingredi- ents : Citrate ion , as citric acid or salt ; maximum daily dosage limit 8 grams . ( f ) Glycine ( aminoacetic acid ) . ( g ) Magnesium - containing active in ...
... grams calcium carbonate ) . ( e ) Citrate - containing active ingredi- ents : Citrate ion , as citric acid or salt ; maximum daily dosage limit 8 grams . ( f ) Glycine ( aminoacetic acid ) . ( g ) Magnesium - containing active in ...
229. lappuse
... gram , 500 units of bacitracin in a suitable ointment base : Provided , That it meets the tests and methods of assay in ... grams of neomycin , and 5,000 units of polymyxin B ; Provided , That it meets the tests and methods of assay in ...
... gram , 500 units of bacitracin in a suitable ointment base : Provided , That it meets the tests and methods of assay in ... grams of neomycin , and 5,000 units of polymyxin B ; Provided , That it meets the tests and methods of assay in ...
230. lappuse
... grams of neomycin , and 8,000 units of polymyxin B ; or ( ii ) 400 units of bacitracin , 3.5 milli- grams of neomycin , and 5,000 units of polymyxin B ; or ( iii ) 500 units of bacitracin , 3.5 milli- grams of neomycin , and 5,000 units ...
... grams of neomycin , and 8,000 units of polymyxin B ; or ( ii ) 400 units of bacitracin , 3.5 milli- grams of neomycin , and 5,000 units of polymyxin B ; or ( iii ) 500 units of bacitracin , 3.5 milli- grams of neomycin , and 5,000 units ...
231. lappuse
... grams of neomycin , 8,000 units of poly- myxin B , and any single generally rec- ognized as safe and effective amine or " caine " -type local anesthetic active ingredient ; or ( ii ) 400 units of bacitracin , 3.5 milli- grams of ...
... grams of neomycin , 8,000 units of poly- myxin B , and any single generally rec- ognized as safe and effective amine or " caine " -type local anesthetic active ingredient ; or ( ii ) 400 units of bacitracin , 3.5 milli- grams of ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning